HeartSciences (HSCS) Shareholder's Equity (QoQ) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | HeartSciences | 4.56 Mn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -36.59% |
| Oct 31, 2025 | 33.15% |
| Jul 31, 2025 | 1,430.97% |
| Apr 30, 2025 | -88.52% |
| Jan 31, 2025 | -55.52% |
| Oct 31, 2024 | -32.31% |
| Jul 31, 2024 | -18.91% |
| Apr 30, 2024 | -15.25% |
| Jan 31, 2024 | 623.36% |
| Oct 31, 2023 | -217.43% |
| Jul 31, 2023 | -325.41% |
| Apr 30, 2023 | 189.39% |
| Jan 31, 2023 | -123.82% |
| Oct 31, 2022 | -62.50% |
| Jul 31, 2022 | 147.68% |
| Apr 30, 2022 | -47.64% |
| Jan 31, 2022 | -19.16% |
| Oct 31, 2021 | -42.93% |